经鼻高流量湿化氧疗对急性心源性肺水肿患者的临床疗效

doi:10.6040/j.issn.1671-7554.0.2019.1313

摘要/Abstract

摘要： 目的分析经鼻高流量湿化氧疗对急性心源性肺水肿患者的临床疗效。方法选取2018年10月1日至2019年8月1日于山东大学附属省立医院老年呼吸科因急性心源性肺水肿住院患者14例为治疗组,给予高流量湿化氧疗,分析临床疗效。另外选取同期于山东大学附属省立医院老年呼吸科住院并给予常规氧疗的心源性肺水肿患者12例作为对照组,对比两组患者呼吸频率、血氧饱和度、呼吸困难指数(mMRC)、舒适度等指标。结果治疗组患者均达到有效的临床控制,心源性肺水肿得到有效治疗,症状及体征好转,氧合指数上升(P=0.048)。与对照组比较治疗组患者0.5、1 h 时呼吸频率、心率及mMRC较低,6 h时心率较低, 12 h时呼吸频率、心率较低, 24 h时心率较低。结论经鼻高流量湿化氧疗对急性心源性肺水肿患者有明确的临床疗效。

关键词: 经鼻高流量湿化氧疗, 心源性肺水肿, 临床疗效

Abstract: Objective To explore the clinical efficacy of high flow nasal cannulae(HFNC)therapy for patients with cardiogenic pulmonary edema. Methods A total of 14 patients with cardiogenic pulmonary edema treated with HFNC therapy during ist Oct. 2018 and ist Aug. 2019 were selected as the treatment group, and another 12 patients with cardiogenic pulmonary edema who received routine oxygen therapy during the same period served as the control group. The respiratory rate, blood oxygen saturation, comfort and other indicators of the two groups were compared. Results All patients in the treatment group achieved effective clinical control, pulmonary edema was effectively treated, symptoms and signs were improved, and oxygenation indexes were increased (P=0.048). Compared with control group, treatment group had lower 0.5 h, 1 h and 12 h respiratory rate; lower 0.5 h, 1 h, 6 h, 12 h and 24 h heart rate; and lower 1 h mMRC. Conclusion HFNC therapy is effective in the treatment of cardiogenic pulmonary edema.

Key words: High flow nasal cannulae therapy, Cardiogenic pulmonary edema, Clinical efficacy

中图分类号:

R563

张国英,王静,王传霞,张玄,迟翔宇,李青. 经鼻高流量湿化氧疗对急性心源性肺水肿患者的临床疗效[J]. 山东大学学报 (医学版), 2020, 58(1): 77-80.

ZHANG Guoying, WANG Jing, WANG Chuanxia, ZHANG Xuan, CHI Xiangyu, LI Qing. Efficacy of high flow nasal cannulae therapy for acute cardiogenic pulmonary edema[J]. Journal of Shandong University (Health Sciences), 2020, 58(1): 77-80.

参考文献

[1] Schmickl CN, Pannu S, Al-Qadi MO, et al. Decision support tool for differential diagnosis of Acute respiratory Distress Syndrome(ARDS)vs Cardiogenic Pulmonary Edema(CPE): a prospective validation and meta-analysis [J]. Crit Care, 2014, 18(6): 659-667.
[2] Pagano A, Numis FG, Rosato V, et al. Pressure support ventilation vs Continuous positive airway pressure for treating of acute cardiogenic pulmonary edema:a pilot study [J]. Respir Physiol Neurobiol, 2018, 255(4): 7-10.
[3] Lee JH, Rehder KJ, Williford L, et al. Use of high flow nasal cannula in critically ill infants,children,and adults: a critical review of the literature [J]. Intensive Care Med, 2013, 39(2): 247-257.
[4] Nishimura M. High-flow nasal cannula oxygen therapy in adults: Physiological benefits, indication, clinical benefits, and adverse effects [J]. Respir Care, 2016, 61(4): 529-541.
[5] Sitthikarnkha P, Samransamruajkit R, Prapphal N, et al. High flow nasal cannula versus conventional oxygen therapy in children with respiratory distress [J]. Indian J Crit Care Med, 2018, 22(5): 321-325.
[6] 许迎辉, 李响, 李哲勇, 等. 经鼻高流量湿化氧疗在急性呼吸衰竭中的应用效果[J]. 中国当代医药, 2018, 25(24): 75-77. XU Yinghui, LI Xiang, LI Zheyong, et al. Application effect of nasal high flow humidified oxygen therapy in acute respiratory failure [J]. China Modern Medicine, 2018, 25(24): 75-77.
[7] 沈悦好, 刘素彦. 经鼻高流量湿化氧疗在呼吸系统疾病中的研究进展[J]. 中国医学创新, 2017, 14(36): 145-148. SHEN Yuehao, LIU Suyan. Research progress of transnasal high flow humidification oxygen therapy in respiratory diseases [J]. Medical Innovation of China, 2017, 14(36): 145-148.
[8] 王晓丹, 张玉想. 经鼻高流量湿化氧疗在急性呼吸衰竭中的作用研究进展[J]. 国际呼吸杂志, 2017, 37(6): 477-480. WANG Xiaodan, ZHANG Yuxiang. Research advances in the role of HFNC in acute respiratory failure [J]. International Journal of Respiration, 2017, 37(6): 477-480.
[9] 解立新, 詹庆元. 成人经鼻高流量湿化氧疗临床规范应用专家共识[J]. 中华结核和呼吸杂志, 2019, 42(2): 83-91. XIE Lixin, ZHAN Qingyuan. Expert consensus of high-flow nasal cannula oxygen therapy on clinical application regularity [J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2019, 42(2): 83-91.
[10] Spoletini G, Alotaibi M, Blasi F, et al. Heated humidified high-flow nasal oxygen in adults: mechanisms of action and clinical implications [J]. Chest, 2015, 148(1): 253-261.
[11] Frat JP, Thme Aw, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemjc respiratory failure [J]. N Engl J Med, 2015, 372(23): 2185-2196.
[12] Ischaki E, Pantazopoulos I, Zakynthinos S. Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device [J].Eur Respir Rev, 2017, 26(145). pii:170028. doi: 10.1183/16000617. 0028-2017.
[13] Sztrymf B, Messika J, Mayot T, et al. Impact of high-flow nasal cannula oxygen therapy on intensive care unit participants with acute respiratory failure: a prospective observational study [J]. J Crit Care, 2012, 27(3): 324.e9-13. doi: 10.1016/j.jcrc.2011.07.075.
[14] Schwabbauer N, Berg B, Blumenstock G, et al. Nasal high-flow oxygen therapy in participants with hypoxic respiratory failure: effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation(NIV)[J]. BMC Anesthesiol, 2014, 14: 66. doi: 10.1186/1471-2253-14-66.
[15] 王建军, 姜宏英, 李勍. 经鼻高流量湿化氧疗与无创正压通气治疗慢性阻塞性肺疾病急性加重伴Ⅱ型呼吸衰竭的随机对照研究[J]. 中国急救医学, 2019, 39(10): 945-948.
[16] 伯梦云, 万秋, 唐莉歆. 经鼻高流量湿化氧疗与无创正压通气对慢阻肺高碳酸血症的治疗效果对比分析[J]. 医药前沿, 2019, 9(24): 467-68.
[17] Carratalft Perales Jm, Llorens P, Brouzet B, et al. High-flow therapy via nasal cannula in acute heart failure [J]. Rev Esp Cardiol, 2011, 64(8): 723-725.
[18] 胡志青, 叶正龙. 经鼻高流量湿化氧疗在急性心力衰竭的临床研究进展[J]. 中国临床研究, 2019, 32(4): 564-565.
[19] Sztrymf B, Messika J, Bertrand F, et al. Beneficial effects of humidified high flow nasal oxygen in critical care participants: a prospective pilot study [J]. Intensive Care Med, 2011, 37(1): 1780-1786.
[20] Schwabbauer N, Berg B, Blumenstock G, et al. Nasal high-flow oxygen therapy in participants with hypoxic respiratory failure: effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation(NIV)[J]. BMC Anesthesiol, 2014, 14: 66. doi:10.1186/1471-2253-14-66.
[21] Rittayamai N, Tscheikuna J, Praphruetkit N, et al. Use of high-flow nasal cannula for acute dyspnea and hypoxemia in the emergency department [J]. Respir Care, 2015, 60(10): 1377-1382.
[22] Carratalá Perales JM, Llorens P, Brouzet B, et al. high-flow therapy via nasal cannula in acute heart failure [J]. Rev Esp Cardiol, 2011, 64(8): 723-725.
[23] Roca O, Pérez-Terán P, Masclans JR, et al. Participants with New York Heart Association class III heart failure may benefit with high flow nasal cannula supportive therapy [J]. J Crit Care, 2013, 28(5): 741-746.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed